SENSOGENIC – Innovative Biosensor for detection of Food Allergens

2019-09-04T05:52:22+00:00September 4th, 2019|innovation, Life Sciences, Medical, Medical device|0 Comments

SensoGenic Ltd. is a Science and Technology Company based in Israel, that is developing food allergens biosensor which is a portable, handheld, a digital diagnostic analyzer for consumers.  The company’s mission is to empower food allergy sufferers and their families with the freedom to enjoy eating safely any place, anytime and anywhere.  SensoGenic’s biosensor is based on advanced nanotechnology science and patents to accurately measure specific protein of interest.

SensoGenic Technology

SensoGenic technology allows food allergy suffers to safely eat and avoid allergic reactions.

Sensogenic biosensor:

  • Portable Biosensor for multiple food allergens in a single test
  • Reports back to a smart device when allergens are detected

SensoGenic, has developed a handheld digital food allergen biosensor for consumers.  It’s the only such device capable of detecting and identifying all the common allergens — milk, eggs, peanuts, tree nuts, wheat, soy, fish and shellfish — from a single food sample placed on a disposable pad and analyzed by the battery-operated biosensor unit.

SensoGenic’s device uses patented nanotechnology to detect specific allergy-causing proteins at a level of 10 ppm (parts per million), considered the lowest adverse reaction level. Users get results on their smartphone via a dedicated app.

In the SensoGenic biosensor, all allergens in the food sample naturally bind with the cellulose nanocrystals on the disposable pad. Once captured, they are individually identified using low-cost commercial antibodies.

Oded Shoseyov is cofounder of the company – all connected in some way to his many cellulose studies. His brother David is the startup’s chief scientific officer.

SensoGenic recently received a €50,000 Horizon 2020 grant from the European Union and is an alumni of the Merage Institute’s Innovation Bridge Leadership Program assisting Israeli life-sciences startups in reaching the American market.  The first target will be the parents of approximately 2.2 million American children allergic to eggs or peanuts.

Yasovsky, Founder & CEO, sees the device as providing “an additional layer of information for decision-making. You should ask the chef what’s in the food, and use our sensor, to make a good decision about whether it’s safe to eat.”

Israeli companies excel in providing cutting edge technologies. All can benefit from the advanced Israel technology. Interested officials are invited to contact the Economic and Trade Department at the Israeli Consulate General in Bengaluru.

For further queries, contact:  Ms. Veshala Gajaraj, Trade Officer in Bengaluru.
Ph: +91-80-4940 6517    Veshalakshe.Gajaraj@israeltrade.gov.il

Leave A Comment